Clinical · specific indications. This label summarises the type of data; it is neither a recommendation to use nor a safety rating.
How we read studies and personal accounts ↗Identity
Nabilone is a synthetic molecule chemically related to THC. The US Cesamet label describes oral capsules; it is neither a plant strain nor another name for CBD.
Terms associated with this entry: nabilone, Cesamet.
The indication matters
A medicine needs to be described in terms of the condition, intended outcome and regulatory context. A useful effect in one setting cannot be assigned to every product called a cannabinoid. Nor does it establish every benefit mentioned in a personal account.
What has been studied
In the United States, Cesamet is indicated for chemotherapy-associated nausea and vomiting after an inadequate response to conventional antiemetic treatment. This is not approval for every kind of nausea.
A 2015 crossover trial involving ten male military personnel found a favourable signal for PTSD-related nightmares. Its size and population sharply limit generalisation; it does not establish a recommendation for ordinary insomnia.
Risks and gaps
Drowsiness, dizziness, concentration problems and mood changes can occur. More serious reactions, including hallucinations and rapid heartbeat, are described. Clinical supervision is part of the medicine’s context.
Nabilone can be habit-forming. A medical indication does not make it harmless or interchangeable with a commercial oil.
Documented forms
| Medicinal capsules | The documented oral presentation is a medicine. This entry does not assign evidence to nabilone in flowers, resins, creams or vaping liquids. |
|---|
A molecule and a product are different things. Read about flowers, resins, oils, creams, capsules and vaping.
Experiences
We have not included a verifiable individual account in this review. We do not fill that gap with commercial stories or invented experiences.
Conclusion
The useful question is which specific indication is being discussed. Nabilone, plant-derived THC and commercial preparations are different things. The regulatory label and original trial show the limits of each claim.
Legal context
Read the Spain note and official sources. Absence from a cited list does not establish that a product is lawful.
Sources
- Cesamet: US prescribing information · Official body
- MedlinePlus: nabilone · Official body
- Jetly et al.: preliminary PTSD nightmare trial (2015) · Human trial
Source review: 2026-11-02. No external clinical review. Corrections: info@milnubes.com.